Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference Johnson & Johnson (NYSE: JNJ) will participate in Citi's 2022 Virtual Healthcare Conference on Wednesday, February 23rd, Ashley McEvoy, Executive...

Key Takeaway: NEW BRUNSWICK, N.J. , Jan. 27, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in Citi's 2022 Virtual Healthcare Conference on Wednesday, February 23 rd , Ashley McEvoy , Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company
Price reaction · baseline $168.38 (2022-01-26 close) · hit after-hours · clean, no other JNJ news in the window
day 0 close · peak
+1.3%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , Jan. 27, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in Citi's 2022 Virtual Healthcare Conference on Wednesday, February 23 rd , Ashley McEvoy , Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time) .
This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com .
A webcast and podcast replay will be available approximately 48 hours after the live webcast.
Last updated: Jan 27, 2022